American Hospital Association June 30, 2021
The Food and Drug Administration identified 43 new drug and biological product shortages in 2020, down from 51 in 2019, and 86 ongoing shortages from prior years, according to the agency’s latest annual report to Congress on the issue.
“Although the number of new drug shortages has declined since 2011 as a result of work by many groups, including FDA, shortages continue to pose a real challenge to public health,” the report notes. “This is especially the case when the shortage involves a critical drug to treat cancer, to provide parenteral nutrition, or to address another serious medical condition,...
Today's Sponsors
Today's Sponsor